The automatic detection of diabetic kidney disease from retinal vascular parameters combined with clinical variables using artificial intelligence in type-2 diabetes patients

被引:6
|
作者
Shi, Shaomin [1 ,2 ]
Gao, Ling [2 ]
Zhang, Juan [1 ]
Zhang, Baifang [3 ]
Xiao, Jing [2 ]
Xu, Wan [2 ]
Tian, Yuan [2 ]
Ni, Lihua [1 ]
Wu, Xiaoyan [1 ,4 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Nephrol, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China
[2] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Affiliated Hosp, Xiangyang 441000, Hubei, Peoples R China
[3] Wuhan Univ, TaiKang Med Sch, Sch Basic Med Sci, Dept Biochem, Wuhan 430071, Hubei, Peoples R China
[4] Wuhan Univ, Zhongnan Hosp, Dept Gen Practice, 169 Donghu Rd, Wuhan 430071, Hubei, Peoples R China
关键词
Diabetic kidney disease; Diabetic retinopathy; Type; 2; diabetes; Fundus photography; Artificial intelligence; RETINOPATHY; NEPHROPATHY;
D O I
10.1186/s12911-023-02343-9
中图分类号
R-058 [];
学科分类号
摘要
BackgroundDiabetic kidney disease (DKD) has become the largest cause of end-stage kidney disease. Early and accurate detection of DKD is beneficial for patients. The present detection depends on the measurement of albuminuria or the estimated glomerular filtration rate, which is invasive and not optimal; therefore, new detection tools are urgently needed. Meanwhile, a close relationship between diabetic retinopathy and DKD has been reported; thus, we aimed to develop a novel detection algorithm for DKD using artificial intelligence technology based on retinal vascular parameters combined with several easily available clinical parameters in patients with type-2 diabetes.MethodsA total of 515 consecutive patients with type-2 diabetes mellitus from Xiangyang Central Hospital were included. Patients were stratified by DKD diagnosis and split randomly into either the training set (70%, N = 360) or the testing set (30%, N = 155) (random seed = 1). Data from the training set were used to develop the machine learning algorithm (MLA), while those from the testing set were used to validate the MLA. Model performances were evaluated.ResultsThe MLA using the random forest classifier presented optimal performance compared with other classifiers. When validated, the accuracy, sensitivity, specificity, F1 score, and AUC for the optimal model were 84.5%(95% CI 83.3-85.7), 84.5%(82.3-86.7), 84.5%(82.7-86.3), 0.845(0.831-0.859), and 0.914(0.903-0.925), respectively.ConclusionsA new machine learning algorithm for DKD diagnosis based on fundus images and 8 easily available clinical parameters was developed, which indicated that retinal vascular changes can assist in DKD screening and detection.
引用
收藏
页数:10
相关论文
共 38 条
  • [31] Effect of switching to teneligliptin from other dipeptidyl peptidase-4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease
    Kitada, Munehiro
    Ogura, Yoshio
    Nitta, Kyoko
    Fujii, Mizue
    Kanasaki, Keizo
    Konishi, Kazunori
    Iida, Yasuo
    Nakagawa, Atsushi
    Koya, Daisuke
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 706 - 713
  • [32] Efficacy and safety of polyethylene glycol loxenatide in treating mild-to-moderate diabetic kidney disease in type 2 diabetes patients: a randomized, open-label, clinical trial
    Cao, Yongsheng
    Cao, Shujie
    Zhao, Jiangang
    Zhao, Jianqin
    Zhao, Yanan
    Liu, Ying
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [33] A J-shaped relationship between ketones and the risk of diabetic kidney disease in patients with type 2 diabetes: New insights from a cross-sectional study
    Liu, Ying
    Wang, Jingyu
    Xu, Fang
    Zhang, Shuang
    Cui, Shanshan
    Li, Yongmei
    Wang, Xiaoyu
    Zheng, Hui
    Li, Junfeng
    Kong, Yan
    Yang, Juhong
    Jiang, Xia
    Chang, Baocheng
    DIABETES OBESITY & METABOLISM, 2023, 25 (11) : 3317 - 3326
  • [34] Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
    Nakanishi, Shuhei
    Hirukawa, Hidenori
    Shimoda, Masashi
    Tatsumi, Fuminori
    Kohara, Kenji
    Obata, Atsushi
    Okauchi, Seizo
    Katakura, Yukino
    Sanada, Junpei
    Fushimi, Yoshiro
    Kan, Yuki
    Tomita, Akiko
    Isobe, Hayato
    Iwamoto, Hideyuki
    Takahashi, Kaio
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 155
  • [35] Association between neutrophil-percentage-to-albumin ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study from NHANES 2009-2018
    Li, Hongying
    Xu, Yue
    Fan, Shuhan
    Wang, Ziming
    Chen, Hao
    Zhang, Lin
    Lu, Yun
    Miao, Yifan
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [36] Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
    Willis, Michael
    Nilsson, Andreas
    Kellerborg, Klas
    Ball, Philip
    Roe, Rupert
    Traina, Shana
    Beale, Rebecca
    Newell, Isabelle
    DIABETES THERAPY, 2021, 12 (01) : 313 - 328
  • [37] Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
    Michael Willis
    Andreas Nilsson
    Klas Kellerborg
    Philip Ball
    Rupert Roe
    Shana Traina
    Rebecca Beale
    Isabelle Newell
    Diabetes Therapy, 2021, 12 : 313 - 328
  • [38] Utilization of glucagon-like peptide-1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records database
    Hirose, Naoki
    Tsujimoto, Naoto
    Katayose, Taeko
    Chin, Rina
    DIABETES OBESITY & METABOLISM, 2022, 24 (03) : 486 - 498